I-ON Communications Announces March Results, Business Development Updates, and Reaffirms 2018-2019 Business Outlook

SEOUL, South Korea, March 21, 2019 /PRNewswire/ -- I-ON Communications Co., Ltd.("I-ON" or the "Company"),.....»»

I-ON Communications Announces 2017 Results and 2018-2019 .....»»

SHANGHAI, March 30, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to.....»»

ROCKVILLE, Md., March 29, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a U.S. pharmaceutical company with a platform to develop and accelerate the.....»»

HONG KONG, March 28, 2019 /PRNewswire/ -- Highlights of the annual results for the year ended December 31, 2018: New 5G devices and applications have created a new opportunity for the Group's business growth......»»

SAN DIEGO, March 15, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:.....»»

HOUSTON, March 07, 2019 (GLOBE NEWSWIRE) -- Lilis Energy, Inc. (NYSE:LLEX), an exploration and development company operating in the Permian Basin of West Texas and Southeastern New Mexico, today announced its 2018 fourth-quarter and full-year re.....»»

NEW YORK, Nov. 28, 2018 /PRNewswire/ -- Golub Capital BDC, Inc., a business development company (NASDAQ:GBDC), today announced its financial re.....»»

PURCHASE, N.Y., Jan. 14, 2019 (GLOBE NEWSWIRE) -- MVC Capital, Inc. (NYSE:MVC) (the Company), a publicly traded business development company (BDC) that makes private debt and equity investments, announced its financial results for the fiscal fourth quar.....»»

Geneva, Switzerland and Boston, MA –February 27, 2019 - ObsEva SA (NASDAQ:OBSV), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman.....»»

SANTA MONICA, Calif., Feb. 28, 2019 /PRNewswire/ -- BlackRock TCP Capital Corp. ("we," "us," "our," "TCPC" or the "Company"), a business development company (NASDAQ:TCPC), today announced its financial results for th.....»»

HONOLULU, April 6, 2020 /PRNewswire/ -- Matson, Inc. (NYSE:MATX) announces preliminary first quarter financial results, amendments to its bank and long-term note agreements to enhance liquidity, and withdraws its financial outlook for the full year 202.....»»

Oxford, Connecticut, March 31, 2020 (GLOBE NEWSWIRE) -- Nxt-ID, Inc. (NASDAQ: NXTD) (the "Company"), a provider of healthcare devices and services, announces results for the year and three months ended December 31, 2019. Financial Highlights and r.....»»

FORT LEE, N.J., March 31, 2020 /PRNewswire/ -- Jerrick Media Holdings, Inc. (OTCQB:JMDA) (the "Company" or "Jerrick") today.....»»

DAVIS, Calif., March 25, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc. (NASDAQ:RKDA), a leader in science-based approaches to enhancing the quality and nut.....»»

SOUTH SAN FRANCISCO, Calif., March 24, 2020 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using .....»»

CAMBRIDGE, Mass., March 16, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC) (LogicBio or the Company), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patient.....»»

RADNOR, Pa., March 16, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today provided a busi.....»»

PALO ALTO, Calif., March 16, 2020 /PRNewswire/ -- Kodiak Sciences Inc. (NASDAQ:KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalen.....»»

PALO ALTO, Calif., March 13, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today reported financial resul.....»»